Typec Meeting Supports Global Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U.S. Food and Drug Administration (FDA) Guidance in Type C Meeting Supports Global Phase 3 Trial in Early-stage Choroidal MelanomaEnrollment Complete in Phase 2 Trial in Choroidal Melanoma Using Suprachoroidal Route of AdministrationBOSTON (BUSINESS WIRE) Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biot.

United statesLos pinosBelzupacap sarotalocanPatrick nealonOncology divisionDrug administrationClinical development operationsAura biosciences incSenior leadership teamExchange commissionTypec meeting supports global phaseEarly stage choroidalChoroidal melanoma using suprachoroidal routeAura biosciencesElisabet de los pinosChief executive officer